SMTL ID : 4xrz.1 (3 other biounits)

Human Cytochrome P450 2D6 BACE1 Inhibitor 6 Complex

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

monomer

Ligands

1 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)

HEM.1: 26 residues within 4Å: Chain A: R.79, V.97, F.98, W.106, R.110, I.164, L.280, A.283, G.284, T.287, T.291, Q.342, I.347, V.352, H.354, L.377, P.413, F.414, S.415, R.419, C.421, L.422, G.423, L.426, A.427 Ligands: SI6.2 23 PLIP interactions: 23 interactions with chain A, Hydrophobic interactions: A:V.97, A:F.98, A:I.164, A:L.280, A:T.287, A:V.352, A:L.377, A:F.414, A:F.414, A:L.422, A:L.426, A:A.427 Hydrogen bonds: A:F.98, A:S.415, A:S.415 Water bridges: A:V.352 Salt bridges: A:R.79, A:R.79, A:R.110, A:H.354, A:R.419 pi-Stacking: A:F.98 Metal complexes: A:C.421

1 x SI6: (4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(1H-pyrazol-4-yl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-d][1,3]thiazin-2-amine(Non-covalent)

SI6.2: 13 residues within 4Å: Chain A: F.98, A.187, G.190, L.191, E.194, Q.222, D.279, S.282, A.283, V.286, T.287, F.461 Ligands: HEM.1 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:F.98, A:A.283, A:T.287 Hydrogen bonds: A:E.194 pi-Stacking: A:F.98 Halogen bonds: A:S.282

4 x ZN: ZINC ION(Non-covalent)

ZN.3: 4 residues within 4Å: Chain A: C.169, H.236, D.248, E.251 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:H.236, A:D.248, A:E.251 ZN.4: 2 residues within 4Å: Chain A: Q.319, H.441 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:H.441 ZN.5: 3 residues within 4Å: Chain A: D.400, Q.402, H.404 2 PLIP interactions: 2 interactions with chain A Metal complexes: A:D.400, A:H.404 ZN.7: 1 residues within 4Å: Chain A: H.302 3 PLIP interactions: 1 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:H.302, H2O.1, H2O.3

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.6: 3 residues within 4Å: Chain A: L.88, Q.222, D.279 No protein-ligand interaction detected (PLIP)

1 x NA: SODIUM ION(Non-functional Binders)

NA.8: 1 residues within 4Å: Chain A: E.424 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:E.424

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Brodney, M.A. et al., Utilizing Structures of CYP2D6 and BACE1 Complexes To Reduce Risk of Drug-Drug Interactions with a Novel Series of Centrally Efficacious BACE1 Inhibitors. J.Med.Chem. (2015)

Release Date

2015-05-20

Peptides

Cytochrome P450 2D6: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cytochrome P450 2D6

Related Entries With Identical Sequence